Prof. Dr. Siret Ratip
Is this your profile? Claim it and verify your details.
Claim profilePerson ↔ Disease
Which diseases does this doctor work on?
-
beta-Thalassemia 3 publicationsSource: OpenAlex / PubMed MeSHView publications
- Lymphoma, Non-Hodgkin 2 publications
- Graft vs Host Disease 2 publications
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 publications
- Leukemia, Myeloid, Acute 2 publications
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.
- Kemik İliği Nakli
- Akut Lenfoblastik Lösemi (ALL)
- Hücresel Tedaviler
- Akut Miyeloid Lösemi (AML)
- Car T Cell Tedavisi
- Kemik İliği Hastalıkları
- KML (Kronik Miyeloid Lösemi)
- Multipl Miyelom
CV
Education and experience
Experience
- 2002Acıbadem Sağlık Grubuacibadem.com.tr
- 2000Marmara Üniversitesi Tıp Fakültesi Hastanesiacibadem.com.tr
- 1998Marmara Üniversitesi Tıp Fakültesi Hastanesiacibadem.com.tr
- 1996 - 2002Marmara Üniversitesi Tıp Fakültesiacibadem.com.tr
- 1996University College Hospitalacibadem.com.tr
- 1995 - 1998Marmara Üniversitesi Tıp Fakültesi Hastanesiacibadem.com.tr
- 1994 - 1995University College Hospital, Londraacibadem.com.tr
- 1994 - 1995University College Hospitalacibadem.com.tr
- 1996University College Hospital, Londra / Hemotoloji Doktorasıacibadem.com.tr
- 1993Mastır Klinik Genetik, Institute of Child Health, Londraacibadem.com.tr
Education
- 2000Marmara Üniversitesi Tıp Fakültesi / Doçent, Digeracibadem.com.tr
- 1998Marmara Üniversitesi Tıp Fakültesi, Hematoloji, Üst Uzmanlıkacibadem.com.tr
- 1994Marmara Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
- 1987King's College School of Medicine Tıp Fakültesi, Üniversiteacibadem.com.tr
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyHaematologyacibadem.com.trFrom source
- Department name at the sourceKemik İliği Nakli Merkezi (Erişkin)acibadem.com.trFrom source
- InstitutionAcıbadem Altunizade Hastanesiacibadem.com.trFrom source
- Area of workbeta-ThalassemiaExtracted from 3 publications · Model version —From source
- Publications45 publicationsOpenAlexFrom source
- Last synchronised4 November 2026 20:45https://www.acibadem.com.tr/doktor/siret-ratip/acibadem.com.tr
Scientific work
Publications on beta-Thalassemia
-
Improving outcomes in patients' refractory to standard therapies: Dual-Mechanism to Mitigate Antigen Escape for Bridge-to-Transplant Immunotherapy
AHFE international, 2026
DOI 10.54941/ahfe1007478 Source: OpenAlex
-
A Germline Variant of BNIP1 Gene (rs28199) is Associated with Familial Multiple Myeloma
Trakya University's Institutional Open Access System (Trakya University), 2025
Source: OpenAlex
-
P-194 A Germline Variant of BNIP1 Gene (rs28199) is Associated with Familial Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia, 2024
DOI 10.1016/s2152-2650(24)02097-4 Source: OpenAlex
-
Comparison of single day versus two-and three- day fractionated infusion of peripheral stem cells in autologous transplantation
Acibadem Universitesi Saglik Bilimleri Dergisi, 2024
DOI 10.31067/acusaglik.1454975 Source: OpenAlex
-
Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases
British Journal of Haematology, 2023
DOI 10.1111/bjh.19271 PMID 38115798 4 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection
Research Square, 2023
DOI 10.21203/rs.3.rs-1042702/v2 Source: OpenAlex
-
Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection
Research Square, 2023
DOI 10.21203/rs.3.rs-1042702/v3 Open-access full textSource: OpenAlex
-
P1397: THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
HemaSphere, 2023
DOI 10.1097/01.hs9.0000972476.61639.77 Source: OpenAlex
-
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application
Turkish Journal of Hematology, 2022
DOI 10.4274/tjh.galenos.2022.2022.0193 PMID 35848614 7 citations (Europe PMC) Open-access full textSource: OpenAlex
-
Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates
Scientific Reports, 2021
DOI 10.1038/s41598-021-83930-6 PMID 33707532 19 citations (Europe PMC) Open-access full textSource: OpenAlex